6.
Nkum B, Micah F, Ankrah T, Nyan O
. Left ventricular hypertrophy and insulin resistance in adults from an urban community in The Gambia: cross-sectional study. PLoS One. 2014; 9(4):e93606.
PMC: 3976294.
DOI: 10.1371/journal.pone.0093606.
View
7.
Saloner R, Sun-Suslow N, Morgan E, Lobo J, Cherner M, Ellis R
. Plasma biomarkers of vascular dysfunction uniquely relate to a vascular-risk profile of neurocognitive deficits in virally-suppressed adults with HIV. Brain Behav Immun Health. 2022; 26:100560.
PMC: 9685288.
DOI: 10.1016/j.bbih.2022.100560.
View
8.
McCutchan J, Marquie-Beck J, Fitzsimons C, Letendre S, Ellis R, Heaton R
. Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder. Neurology. 2012; 78(7):485-92.
PMC: 3280051.
DOI: 10.1212/WNL.0b013e3182478d64.
View
9.
Kaddu-Mukasa M, Ssekasanvu E, Ddumba E, Thomas D, Katabira E
. Rheumatic manifestations among HIV positive adults attending the Infectious Disease Clinic at Mulago Hospital. Afr Health Sci. 2011; 11(1):24-9.
PMC: 3092320.
View
10.
Hooi J, Kester A, Stoffers H, Rinkens P, Knottnerus J, Van Ree J
. Asymptomatic peripheral arterial occlusive disease predicted cardiovascular morbidity and mortality in a 7-year follow-up study. J Clin Epidemiol. 2004; 57(3):294-300.
DOI: 10.1016/j.jclinepi.2003.09.003.
View
11.
Sheehan D, Lecrubier Y, Sheehan K, Amorim P, Janavs J, Weiller E
. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1999; 59 Suppl 20:22-33;quiz 34-57.
View
12.
Saylor D, Dickens A, Sacktor N, Haughey N, Slusher B, Pletnikov M
. HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment. Nat Rev Neurol. 2016; 12(4):234-48.
PMC: 4937456.
DOI: 10.1038/nrneurol.2016.27.
View
13.
Mackenzie I, Wilkinson I, Cockcroft J
. Assessment of arterial stiffness in clinical practice. QJM. 2002; 95(2):67-74.
DOI: 10.1093/qjmed/95.2.67.
View
14.
Ataklte F, Erqou S, Kaptoge S, Taye B, Echouffo-Tcheugui J, Kengne A
. Burden of undiagnosed hypertension in sub-saharan Africa: a systematic review and meta-analysis. Hypertension. 2014; 65(2):291-8.
DOI: 10.1161/HYPERTENSIONAHA.114.04394.
View
15.
Sacktor N, Skolasky R, Seaberg E, Munro C, Becker J, Martin E
. Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study. Neurology. 2016; 86(4):334-40.
PMC: 4776086.
DOI: 10.1212/WNL.0000000000002277.
View
16.
Walker R, Jusabani A, Aris E, Gray W, Mugusi F, Swai M
. Correlates of short- and long-term case fatality within an incident stroke population in Tanzania. S Afr Med J. 2013; 103(2):107-12.
DOI: 10.7196/samj.5793.
View
17.
Howlett W, Urasa S, Maro V, Walker R, Kilonzo K, Howlett P
. Neurological disorders in Northern Tanzania: A 6-year prospective hospital-based case series. Afr Health Sci. 2022; 22(1):269-284.
PMC: 9382522.
DOI: 10.4314/ahs.v22i1.34.
View
18.
Gelpi M, Afzal S, Lundgren J, Ronit A, Roen A, Mocroft A
. Higher Risk of Abdominal Obesity, Elevated Low-Density Lipoprotein Cholesterol, and Hypertriglyceridemia, but not of Hypertension, in People Living With Human Immunodeficiency Virus (HIV): Results From the Copenhagen Comorbidity in HIV Infection.... Clin Infect Dis. 2018; 67(4):579-586.
DOI: 10.1093/cid/ciy146.
View
19.
Agu C, Uchendu I, Nsonwu A, Okwuosa C, Uwadiegwu Achukwu P
. Prevalence and associated risk factors of peripheral artery disease in virologically suppressed HIV-infected individuals on antiretroviral therapy in Kwara state, Nigeria: a cross sectional study. BMC Public Health. 2019; 19(1):1143.
PMC: 6700806.
DOI: 10.1186/s12889-019-7496-4.
View
20.
Beckman J, Duncan M, Alcorn C, So-Armah K, Butt A, Goetz M
. Association of Human Immunodeficiency Virus Infection and Risk of Peripheral Artery Disease. Circulation. 2018; 138(3):255-265.
PMC: 6050082.
DOI: 10.1161/CIRCULATIONAHA.117.032647.
View